Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.19.2
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional paid in capital
Retained earnings/(Accumulated deficit)
Total
Balance at Dec. 31, 2018 $ 431 $ 24,569 $ (451) $ 24,549
Balance in (shares) at Dec. 31, 2018 4,312,500      
Sale of 17,250,000 Units, net of underwriting discounts and offering costs $ 1,725 168,484,174 0 168,485,899
Sale of 17,250,000 Units, net of underwriting discounts and offering costs (in shares) 17,250,000      
Sale of 717,500 Private Units $ 72 7,174,928 0 7,175,000
Sale of 717,500 Private Units (in shares) 717,500      
Common stock subject to possible redemption $ (1,693) (171,039,807) 0 (171,041,500)
Common stock subject to possible redemption (shares) (16,934,802)      
Net income $ 0 0 356,058 356,058
Balance at Mar. 31, 2019 $ 535 4,643,864 355,607 5,000,006
Balance in (shares) at Mar. 31, 2019 5,345,198      
Balance at Dec. 31, 2018 $ 431 24,569 (451) 24,549
Balance in (shares) at Dec. 31, 2018 4,312,500      
Net income       1,035,578
Balance at Jun. 30, 2019 $ 528 3,964,353 1,035,127 5,000,008
Balance in (shares) at Jun. 30, 2019 5,277,919      
Balance at Mar. 31, 2019 $ 535 4,643,864 355,607 5,000,006
Balance in (shares) at Mar. 31, 2019 5,345,198      
Common stock subject to possible redemption $ (7) (679,511) 0 (679,518)
Common stock subject to possible redemption (shares) (67,279)      
Net income $ 0 0 679,520 679,520
Balance at Jun. 30, 2019 $ 528 $ 3,964,353 $ 1,035,127 $ 5,000,008
Balance in (shares) at Jun. 30, 2019 5,277,919